BJ's Restaurants Q2 revenue beats estimates
Reuters2026/07/30 20:33
Overview
US casual dining chain's fiscal Q2 revenue rose 6.4%, beating analyst expectations
Adjusted EPS for fiscal Q2 beat analyst expectations
Company raised 2026 guidance and repurchased $2.4 mln in shares during Q2
Outlook
BJ's Restaurants raises 2026 comparable sales growth outlook to 3.0%-4.0% from 1.0%-3.0%
Company lifts 2026 restaurant-level operating profit forecast to $228 mln-$235 mln
BJ's Restaurants now sees 2026 adjusted EBITDA at $145 mln-$152 mln, up from $140 mln-$150 mln
Result Drivers
GUEST TRAFFIC - Co said comparable restaurant sales growth was driven by an 8.3% increase in guest traffic, outpacing casual dining benchmarks
STRATEGIC INITIATIVES - Management attributed profit growth to continued execution of four strategic pillars and operational improvements
HIGHER GENERAL ADMINISTRATIVE COSTS - Incremental GA costs were related to deferred compensation, legal, and leadership transition expenses, per CFO
Company press release: ID:nGNX9nN6hf
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 Revenue |
Beat |
$388.89 mln |
$377.07 mln (10 Analysts) |
Q2 Adjusted EPS |
Beat |
$0.94 |
$0.89 (10 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the restaurants bars peer group is "buy"
Wall Street's median 12-month price target for BJ's Restaurants Inc is $64.00, about 8.8% below its July 29 closing price of $70.15
The stock recently traded at 28 times the next 12-month earnings vs. a P/E of 14 three months ago
Reuters Recommended Reads
July 28 - Cheesecake Factory Q2 results beat estimates as marketing efforts strengthen consumer engagement
July 29 - Chipotle raises forecast despite hit from cyclospora parasite scare
July 29 - Chefs' Warehouse Q2 sales rise 13%, beat estimates
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Initiator Pharma appoints Annette Säfholm as chief operating business officer
GSC Research sets CEWE price target at EUR 146, reiterates buy rating
Genova exercises call options to buy remaining 49% of Järngrinden for about SEK 800 million